Friday 10 July 2015, Amsterdam
The report, now available on ASDReports, “Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019”, analyzes and studies the major market drivers, restraints/challenges, and opportunities.
This report studies the global hemodynamic monitoring systems market for the forecast period of 2014 to 2019. This market is expected to reach $1,107.4 million by 2019 from $887.8 million in 2014, and is poised to grow at a CAGR of 4.5% during the forecast period.
The global hemodynamic monitoring systems market is segmented on the basis of products, types, end users, and regions.
Based on products, the hemodynamic monitoring systems market is categorized into systems and disposables. In 2014, the disposables segment accounted for a major share of the hemodynamic monitoring systems market.
On the basis of type, the hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive hemodynamic monitoring systems. In 2014 invasive hemodynamic monitoring systems accounted for a major share of the hemodynamic monitoring systems market.
On the basis of end users, the hemodynamic monitoring systems market is segmented into hospitals, cath labs, and home and ambulatory sites. In 2014, the hospitals end-user segment accounted for a major share of the hemodynamic monitoring systems market.
On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). The Rest of the World region comprises Latin America, Pacific countries, and Middle East and Africa. In 2014, North America accounted for the largest share of the hemodynamic monitoring systems market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies offering hemodynamic monitoring systems.
Over the years, the demand for hemodynamic monitoring systems is likely to increase owing to the technological advancements in hemodynamic monitoring systems, growing prevalence of hypertension and diabetes, and rapidly aging population. Moreover, rising aging population in the populous and emerging countries like India and China are likely to create huge opportunities for hemodynamic monitoring systems. However, risks associated with invasive hemodynamic monitoring are restraining the growth of this market.
Some of the major players in the global hemodynamic monitoring systems market include LiDCO Group plc (U.K.), Edwards Lifesciences Corporation (U.S.), Cheetah Medical, Inc. (U.S.), Deltex Medical Group plc (U.K.), ICU Medical, Inc. (U.S.), PULSION Medical Systems SE (Germany), Schwarzer Cardiotek GmbH (Germany), Osypka Medical GmbH (Germany), Hemo Sapiens, Inc. (U.S.), and Tensys Medical, Inc. (U.S.).
Publish date : March 2015
Report code : ASDR-208155
Pages : 153